Author Title Type [ Year(Desc)]
Filters: Author is Haas, Thorsten  [Clear All Filters]
2017
Cushing MM, Fitzgerald MM, Harris RM, Asmis LM, Haas T.  2017.  Influence of cryoprecipitate, Factor XIII, and fibrinogen concentrate on hyperfibrinolysis.. Transfusion. 57(10):2502-2510.
2019
Cushing MM, Asmis LM, Harris RM, DeSimone RA, Hill S, Ivascu N, Haas T.  2019.  Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro.. Transfusion.
2020
Dillard A, DeSimone RA, Hsu Y-M, Ma L, Vasovic L, Racine-Brzostek S, Ivascu N, Haas T, Cushing MM.  2020.  Flat line in the blood bank: code H (hyperfibrinolysis)? Transfusion.
2024
Cushing MM, Cohen T, Fitzgerald MM, Rand S, Sinfort A, Chen D, Keltner N, Ong S, Parra P, Benabdessadek D et al..  2024.  Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): study protocol for a single center, prospective, cluster randomized trial.. Trials. 25(1):625.
2025
Milewski AR, Hoyler MM, Haas T, Cushing MM.  2025.  New device, old algorithm? Bridging generations in perioperative coagulation management. Br J Anaesth.